| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |